Company
Headquarters: Tokyo, Japan
Employees: 1,446
CEO: Mr. Keiichi Shibahara
¥47.46 Billion
JPY as of July 1, 2025
US$331.0 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Amvis Holdings, Inc. provides nursing home, home nursing care, home care, in-home care support, and disability welfare services in Japan. It also offers consulting and other ancillary services. The company was founded in 2013 and is headquartered in Tokyo, Japan.
| Last Financial Reports Date | March 31, 2024 |
| Revenue TTM | ¥42.47 B |
| EBITDA | ¥10.27 B |
| Gross Profit TTM | ¥17.06 B |
| Profit Margin | 17.51% |
| Operating Margin | 20.86% |
| Quarterly Revenue Growth | 30.90% |
Amvis Holdings, Inc. has the following listings and related stock indices.
Stock: JPX: 7071 wb_incandescent